Vensana Capital has successfully closed its third fund, Vensana Capital III, with $425 million in committed capital, surpassing its hard cap and raising its total assets under management to approximately $1 billion. Founded in 2019, Vensana focuses on investing in innovative medical technology companies, particularly in medical devices and data science. The firm has partnered with over 20 companies, achieving six exits worth nearly $3 billion. The team, led by Managing Partners Kirk Nielsen and Justin Klein, includes experienced investors and an advisory board of medical technology experts. They aim to transform healthcare through breakthrough innovations.